RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $60 | -100.0% | 40,159 | -88.6% | 0.00% | -80.0% |
| Q3 2022 | $417,000 | -66.7% | 353,244 | -15.6% | 0.01% | -68.8% |
| Q1 2022 | $1,252,000 | +30.4% | 418,771 | +15.6% | 0.02% | +60.0% |
| Q4 2021 | $960,000 | +954.9% | 362,271 | +1343.3% | 0.01% | +900.0% |
| Q3 2021 | $91,000 | 0.0% | 25,100 | -5.2% | 0.00% | 0.0% |
| Q1 2021 | $91,000 | -12.5% | 26,468 | -10.8% | 0.00% | 0.0% |
| Q4 2020 | $104,000 | +8.3% | 29,680 | -25.6% | 0.00% | -50.0% |
| Q3 2020 | $96,000 | +128.6% | 39,905 | +72.8% | 0.00% | +100.0% |
| Q2 2020 | $42,000 | +75.0% | 23,099 | +107.7% | 0.00% | – |
| Q4 2019 | $24,000 | -52.0% | 11,120 | -41.4% | 0.00% | -100.0% |
| Q2 2019 | $50,000 | – | 18,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |